Newsroom | 25738 results

SPOKANE, Wash.--(BUSINESS WIRE)--Tegria, a global healthcare consulting and services company, was recognized in the KLAS 2025 Consistent High Performers Report. The report highlights vendors and service firms that consistently deliver strong client satisfaction year after year. “We’re honored to be among the firms recognized as Consistent High Performers by KLAS,” said Brian Cahill, CEO of Tegria. “This recognition is especially meaningful as it is based on our clients’ feedback and is indicati...

WINTER PARK, Fla.--(BUSINESS WIRE)--Humata Health, the leader in AI-powered prior authorization technology, has been selected by the Centers for Medicare & Medicaid (CMS) as a key partner for its WISeR model, an initiative focused on safeguarding patients and protecting Medicare funds. Humata will use its proprietary technology to help build a more modern, efficient and fair clinical approval process for CMS, the single largest payer for healthcare in the U.S. The WISeR model — which launch...

BERKELEY HEIGHTS, N.J.--(BUSINESS WIRE)--Summit Health is proud to announce that 55 outstanding physicians have been recognized as 2025 Jersey Choice “Top Doctors” by New Jersey Monthly magazine. This esteemed accolade highlights the exceptional expertise, dedication, and compassionate care our doctors bring to the communities they serve. “Our physicians’ commitment to excellence in patient care is truly inspiring,” said Adam Barrison, MD, Chief Physician Executive of Summit Health and Starling...

LUXEMBOURG--(BUSINESS WIRE)--Auna S.A. (“Auna” or the “Company”), a leading healthcare services provider in Latin America with operations in Mexico, Peru, and Colombia, announced today the closing of a US$765 million debt refinancing that significantly strengthens its capital structure by extending debt maturities, lowering interest expenses, and improving cash flow generation to further invest in the Company’s various strategic growth initiatives. The Company and Oncosalud S.A.C., as co-issuer...

FOSTER CITY, Calif.--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq: GILD) today announced the Phase 3 ASCENT-07 study investigating Trodelvy® (sacituzumab govitecan-hziy) versus chemotherapy as a first-line treatment post-endocrine therapy in HR+/HER2-negative metastatic breast cancer patients did not meet the primary endpoint of progression-free survival (PFS) as assessed by Blinded Independent Central Review (BICR) according to RECIST v1.1 criteria. Overall survival is a key secondary endpoi...

FOSTER CITY, Calif.--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq: GILD) today announced new long-term data reinforcing the safety and efficacy profile of Livdelzi® (seladelpar) for people living with primary biliary cholangitis (PBC). Findings support Livdelzi's consistent efficacy and safety outcomes in patients switching from obeticholic acid and positive impact on liver stiffness over 3 years. These findings were presented at The Liver Meeting® hosted by the American Association for the S...

--(BUSINESS WIRE)--UNH Board Authorizes Payment of Quarterly Dividend...

LOS ANGELES--(BUSINESS WIRE)--City of Hope today announced that Dr. Christine M. Lovly will spearhead the development of its new national thoracic oncology program starting Jan. 1....

MOBILE, Ala.--(BUSINESS WIRE)--TruBridge, Inc. (NASDAQ: TBRG), a leading provider of revenue cycle management and healthcare technology solutions for rural and community healthcare organizations, today announced financial results for the third quarter and nine months ended September 30, 2025. Third Quarter 2025 Highlights All comparisons are to the quarter ended September 30, 2024, unless otherwise noted Total bookings of $15.5 million compared to $21.0 million Total revenue of $86.1 million co...

CONCORD, Calif.--(BUSINESS WIRE)--Cerus Corporation (Nasdaq: CERS) announced today financial results for the third quarter ended September 30, 2025, and provided a business update. “We continue to make great strides in improving the safety and availability of transfused blood components around the globe and the record quarterly product revenue results reflect that progress. Product revenue growth was driven by strong global commercial execution and growing awareness of the benefits conferred by...